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Background: Due to the complex anatomy of the upper cervical spinal column region and the variable
aggressiveness of giant cell tumors (GCTs), there exists no standard treatment for GCTs of axial vertebra. To the best
of our knowledge, there are only a few case reports in the literature and no large sum numbers of clinical trials
about the treatment of, or research into, axial vertebra GCTs.
Methods: Between 2009 and 2013, five patients pathologically diagnosed with axial vertebra GCTs were treated at
our hospital. We performed intralesional excision and odontoid process reconstructive surgery to preserve the
odontoid process, followed with adjuvant radiation therapy after surgery.
Results: For those with an intact bone shell, part of the β-TCP (beta tricalcium phosphate) artificial bone could be
seen clearly after surgery and became blurred three months after surgery, as seen on a radiograph. One year later,
the part of β-TCP artificial bone was fused as a block. Subsequently, autogenous bone regenerated successfully and
artificial bone degraded thoroughly. For those with a defective cortical bone, partial fusion of the odontoid process,
autograft ilium and third vertebra body could be seen three months after surgery, and complete fusion was seen
nine months later. The odontoid process was preserved successfully, and the upper cervical spine was reconstructed
effectively, without implant failure or infection.
Conclusions: In this study, the odontoid process and function of upper cervical vertebra was preserved successfully
through lesion curettage, combined with reconstruction with bone grafting, and adjuvant radiation therapy after
surgery. During the follow-up periods, no recurrence or complications was observed.
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Giant cell tumors of the bone (GCTs), are one of the
most common benign primary bone tumors, and are
well known for their locally aggressive behavior and
tendency to recur [1]. With a slight predominance in
females compared to males, GCTs accounted for ap-
proximately 5% of bone tumors in adults between 20
and 50-years-old globally [2,3]. After the knee and the
radius, the sacrum is the third most common location
of GCTs in bones [4,5] and the most common location
in the axial skeleton. Primary GCTs of the cervical
spine account for only about 2 to 3% of spine tumors,* Correspondence: guozheng87654321@163.com; qingnan610@163.com
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unless otherwise stated.and GCTs in the axial vertebra (C2) are especially rare
[6,7].
Although generally considered a benign tumor, 5 to 10%
of GCTs are reported as malignant and aggressive tumors
[8,9]. The aggressiveness of the tumor led to local recur-
rence in 7 to 75% of patients [9,10]. Of reported GCTs, 1
to 9% metastasize to the lungs despite the fact that the pri-
mary lesion was histologically considered to be benign
[11]. If the tumor is located in a complex and important
region, such as upper cervical spinal column, local recur-
rence and distal aggressiveness of the tumor often has a
serious causality and a high risk of fatality.
Due to the complex anatomy of the upper cervical
spinal column region and the variable aggressiveness
of GCTs, there is no standard treatment procedure forhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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axial vertebra (C2). Traditionally, treatment options for
GCTs included wide resection (Ec bloc), intralesional
curettage with or without adjunctive techniques [12,13]
and radiation therapy [14]. Radiation eliminates surgical
complications to a great extent but may cause local injur-
ies, such as early and late skin injuries, neuritis, secondary
pathologic fractures and so on [13,14]. Wide resection
was theoretically intended to prevent local recurrence, but
it increases surgical morbidity with complications such as
hematoma, functional deficits, skin sloughs and fistulas,
deep infection and problems resulting from reconstruc-
tion for the anatomic structure and biomechanics stability
[15]. Local curettage of the lesion preserves the integrity
of the column, however, the local recurrence rate is espe-
cially high, ranging from 6.3 to 43% [12,13]. The scarcity
of reports in the available literature on this topic provides
limited protocol for clinicians to achieve maximum local
control and minimum surgical complications in patients
with axial vertebra GCTs. However, whether to preserve
the odontoid process of the axial vertebra or not is sub-
stantially important to the anatomy structure and function
preservation of the atlantoaxial vertical joint.
There are only a few case reports in the literature and
no large sum numbers of clinical trials about the treat-
ment of, and research into, axial vertebra (C2) GCTs.
However, to the best of our knowledge, there have been
only a few reports of the preservation of the odontoid
process for axial vertebra tumors [16,17]. Between 2009
and 2013, five patients pathologically diagnosed with
axial vertebra GCTs were treated at our hospital. We
performed intralesional excision and odontoid process
reconstructive surgery to preserve the odontoid process,
followed with adjuvant chemotherapy after surgery. We
introduce the surgical experience of five cases and evalu-
ate retrospectively the effectiveness of this treatment for
axial vertebra GCTs in preserving anatomy structure
and function of the atlantoaxial vertical joint.
Methods
Basic characteristics
We retrospectively reviewed the records of all five patients
who had a primary GCT involving the axial vertebra and
who were treated with surgery between 2009 and 2013.
There were two male and three female patients, with a
mean age of 31 years (23 to 45 years) (Table 1). Three
patients were treated with intralesional surgery and two
patients underwent partial resection to preserve the
odontoid process, all followed with adjuvant radiation
therapy after surgery. The mean follow-up period was
31.4 months (10 to 48 months) for all patients. All five
GCTs were located in a single segment of the axial verte-
bra.We had prior ethics approval from Institutional ethical
committee of Xijing Hospital (NO: 20090135) and patientconsent was obtained for this study. WBB (Weinstein-
Boriani-Biagini anatomic zone classification for tumor)
stages of tumor and Frankel grades of nerve functions are
shown in Table 2.
The research was carried out according to the princi-
ples set out in the Declaration of Helsinki 1964 and all
subsequent revisions. Informed consent was obtained
and the relevant institutional review board had approved
the study.
Clinical information and imaging
The diagnosis of axial vertebra GCT was established based
on clinical information and imaging studies (Figures 1
and 2), and confirmed by pathology examination after
surgery. All five patients with GCTs experienced differ-
ent scales of pain locally in the upper cervical spine and
the pain became increasingly serious. Two patients felt
numbness or pain intensively in the upper limb and had
to take non-steroidal anti-inflammatory drugs orally to
relieve the pain (case two and case four). Two other pa-
tients took on the symptoms or signs of cervical verte-
brae instability and spinal cord compression, such as
shaky gait, hypertonia of the lower extremity muscular
tension, hyperreflexia of patellar tendon, Babinski’s sign
(+) and Hoffmann's sign (+) (case one and case three).
One of the five patients experienced limited motion of
the cervical vertebrae suddenly after a trivial trauma.
Subsequently, she suffered from both dyspnea and dys-
phagia (case five).
The stage of the GCTs were set radiographically ac-
cording to the system of Campanacci [18] as follows: an
intraosseous lesion (Grade I); an intraosseous lesion with
cortical thinning and expansile borders (Grade II) and
an extraosseous lesion, forming a soft tissue mass (Grade
III). There were two patients with Grade I lesions, two
patients with Grade II lesions and one with Grade III
lesions.
Surgical methods
All surgeries were performed by one surgeon under
general endotracheal anesthesia. Arterial blood pres-
sure was monitored and a deep venous cannula was
intubated continuously during the periods of opera-
tions. For all five patients, we fixed the cervical spine
through the posterior approach, combined with lesion
curettage through the anterior approach. Astride across
the axial vertebra (C2), the pedicle of the atlas vertebral
arch (C1) and the lateral mass of the third vertebra (C3)
were fixed together stably using cervical pedicle screw
systems (Medtronic, Minneapolis, USA) through the
posterior approach in three cases (cases one, two and
three). For the anterior approach, the axial vertebra
(C2) was exposed through inner margin approach of the
sternocleidomastoid muscle at the inferior angle of the
Table 1 Basic characteristics of the patients
Case Age Gender Location of the tumor Surgery Follow-up
1 27 Male C2 intralesional curettage 48 months
2 36 Female C2 intralesional curettage 37 months
3 24 Female C2 intralesional curettage 10 months
4 45 Female C2 partial resection 34 months
5 23 Male C2 partial resection 28 months
C2: axial vertebra.
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shell, surgical treatment options were thorough intrale-
sional curettage and preservation of the odontoid process
(Figure 3B). Then the base of lesion was cauterized using
50% zinc chloride for 20 minutes and irrigated three times
with large volumes of saline. The β-TCP artificial bone
(Bio-Lu Bioceramics , Shanghai, China) was implanted
(Figure 4A) in the cavity for reconstruction of the axial
vertebra (C2) [19].
To make sure the fixation was firm, the pedicle of the
atlas vertebral arch (C1) and the lateral mass of third/
fourth vertebra (C3 and C4) were fixed together using
cervical pedicle screws through the posterior approach
in the two cases with pathological fractures of the odont-
oid process (case four and case five). For those with
a defective cortical bone of the axial vertebra (C2), the
axial vertebral body was resected and the odontoid
process was preserved with thorough intralesional curet-
tage through the anterior approach (Figure 3C). Then,
the autograft ilium was cut and trimmed in a ‘kitchen
knife’ outline form, so that the ‘knife holder’ inserted
into the odontoid process preserved and the ‘knife body’
made up for the defect of the axial vertebra body that
had been resected. For the fusion of the odontoid
process, autograft ilium and third cervical vertebra body, a
cervical spinal plate (Medtronic, Minneapolis, USA) was
implanted through the anterior approach (Figure 4B). To
improve local control of the GCT after surgery, three-
dimensional conformal radiation therapy was adminis-
tered (total dose: 30 to 456 Gy) as an adjuvant treatment




Frankel grade Pain (VAS) Recurrence
Pre-op 3 monthsa Pre-op 3 monthsa
1 4-9/B-D E E 6 2 NO
2 4-9/B-D E E 7 3 NO
3 4-9/B-D E E 5 2 NO
4 4-9/A-D D E 6 1 NO
5 4-9/B-D D E 4 1 NO
aPost-operation. NO: no recurrence during the follow up periods; Pre-op:
pre-operation; VAS: Visual Analogue Scale.Results
The mean operation duration was 120 minutes (range:
90 to 180 minutes). The total blood loss was 400 ml
(range: 200 to 800 ml) and most of the blood was lost
during the course of intralesional curettage. The mean
follow-up period was 31.4 months after surgery. Nerve
root pain and local pain eased substantially without any
analgesic one month after surgery. Pain disappeared al-
most three months after surgery. The Visual Analogue
Scale (VAS:0-10 scores) scores for pain were shown in
Table 2. Muscle strength and muscle tension returned to
normal and neural function as measured by the Frankel
grade decreased from D to E at three months after surgery
(Table 2). No recurrence was observed in all five cases
during the follow-up periods. The patient was symptom
free in all five cases at the last time of follow-up.
For those with an intact bone shell, part of the β-TCP
artificial bone could be seen clearly after surgery and be-
came blurred three months after surgery as seen on a
radiograph. One year later, a radiograph showed that the
part of the β-TCP artificial bone had fused as a block.
Subsequently, autogenous bone had regenerated suc-
cessfully and artificial bone had degraded thoroughly
(Figure 4A). For those with a defective cortical bone of
the axial vertebra (C2), partial fusion of the odontoid
process, autograft ilium and third vertebra body could
be seen three months after surgery, and complete fu-
sion could be seen nine months later on a radiograph
(Figure 4B). The odontoid process was preserved success-
fully and the upper cervical spine was reconstructed ef-
fectively without implant failure or infection in all five
cases. Stability and activity of the cervical spine was satis-
factory for all patients.
Discussion
GCTs of the bone were classified by the World Health
Organization (WHO) as a benign but locally aggressive
tumor [20]. They occur most frequently in young adults
between 20 and 40 years of age [21-23]. A higher inci-
dence of GCTs has been reported for the Chinese popu-
lation, in which it can account for up to 20% of all bone
tumors [21,24].
Currently, there is no consensus regarding the ideal
treatment selection for all patients with GCTs. Various
Figure 2 Computed tomography scans showing osteolysis destructio
intact cortical bone of the axial vertebra odontoid process. (A, C) Mag
bone of the axial vertebra and the soft tissue mass that was seen around (
imaging on T1-WI.
Figure 1 Preoperative view: radiograph characteristics of the
pathological axial vertebra (C2). Expansile osteolysis of the axial
vertebra with giant cell tumors (GCTs) and intact cortical bone of
the axial vertebra affected (A, B). Pathological fractures of the
odontoid process and sub-dislocation of the atlantoaxial vertical
joint (C, D). GCTs invaded the cortical bone of the axial vertebra (C2)
and a soft tissue mass was seen around (C).
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recurrence rate of GCTs [21,25]. However, wide resec-
tion is associated with higher rates of surgical complica-
tions [26,27] and is often accompanied by considerable
functional impairment [28]. Instead, intralesional exci-
sion is a preferable treatment when feasible with the aim
of excising the whole tumor and sparing the native joint
[28-30]. However, curettage alone has been associated
with a high rate of local recurrence [26,31]. Therefore,
various adjuvants have been employed to ‘extend’ the
curettage [30,32] and no clear evidence exists as to
whether adjuvant therapies are most effective [33,34].
The fact that there is no single treatment to control the
recurrence of the lesion effectively has created a lot of
studies on GCTs. In this clinical study, we describe our
experience on treating GCTs of the axial vertebra (C2)
and discuss the effectiveness and safety of upper cervical
spine reconstruction following intralesional curettage
surgery.
Recently, it has been widely reported that tumors of
the spine are managed successfully with en bloc resec-
tions whenever possible, as this provides the greatest
chance for cure [35,36]. However, en bloc resections are
almost impossible for the axial vertebra (C2) because
of the complicated anatomy and the important bio-
mechanical functions of it. The anatomy of the upper
cervical spinal column region contains the vertebral
artery, cervical nerve root, cervical spinal cord and
atlantoaxial vertical joint. According to Enneking’s classifi-
cation for bone tumors [37], GCTs of the vertebral col-
umn are classified as Enneking stage three of the spine
benign tumor, that is to say, an aggressive benign tumor.n of the axial vertebra (C2) with giant cell tumors (GCTs) and the
netic resonance imaging showing the GCTs that invaded the cortical
B, D). Tumors and the soft tissue mass are showed as low signal
Figure 3 Surgical approach and skin incision. Skin incision (A). Intralesional curettage for those with an intact bone shell of the odontoid
process and preservation of the odontoid process (B). Partial resection of the axial vertebral body and autograft ilium for those with a defective
cortical bone of the axial vertebra (C).
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treatments for axial vertebra GCTs. In this clinical study,
intralesional curettage, combined with bone grafting, and
adjuvant radiation therapy after surgery, was an effective
therapeutic strategy for all five cases with GCTs. However,
only skillful surgeons would be able to practice those
complicated surgical techniques with skill and ease as it
requires experience to master the surgical approach, lesion
resection and function reconstruction of the upper cer-
vical vertebral column.
Due to the anatomic characteristics of the upper cer-
vical vertebral column, the anterior approach is the most
common surgical technique for the lesion resection ofFigure 4 Follow-up radiograph. For those with an intact bone
shell, part of the β-TCP artificial bone was implanted in the cavity
for reconstruction of the axial vertebra. Forty-eight months
post-operation, autogenous bone had regenerated successfully
and artificial bone had degraded thoroughly (A). For those with a
defective cortical bone of the axial vertebra, an autograft ilium
was implanted and made up for the defect of the axial vertebra
body that had been resected. Twelve months post-operation, the
odontoid process and autograft ilium were shown to have fused
completely on a radiograph (B). No recurrence was observed in
both cases during the follow-up periods.axial vertebra (C2) in the literature [16,17]. It has also
been reported that trans-oral approach surgery or splitting
the mandible approach surgery are frequently used tech-
niques to expose the axial vertebra (C2). The pathological
axial vertebra could be exposed directly and easily through
these approaches, however, there are numerous avoidable
disadvantages. Firstly, it is technically difficult to control
severe bleeding due to the limited operating space in the
trans-oral approach. Secondly, it increases the disunion
incidence of mucous membrane, because the posterior
wall of the pharynx membrane was is thin to contain the
grafting bone and/or internal implants. Thirdly, it in-
creases the contamination rate of incision due to the
non-aseptic atmosphere of the oral cavity. Lastly, recon-
struction of mandible is technically difficult and would
present dysfunction of chewing following the splitting
the mandible approach. However, the approach in our
study overcame the disadvantages of the trans-oral ap-
proach and the splitting the mandible approach. Through
the inner margin of the sternocleidomastoid muscle and
the inferior angle of the mandible incision, the axial verte-
bra (C2) was exposed distinctly and the lesion was curetted
successfully. There were also advantages such as the small
size of incision, the low incidence rate of complication and
so on. Due to the complicated structure of this approach,
the adjacent superior laryngeal nerve, hypoglossal nerve
and submandibular gland should be protected cautiously.
For all five patients, we fixed the cervical spine through
the posterior approach and then curetted the lesion
through the anterior approach. In three of the patients
who had an intact cortex, the odontoid process was pre-
served successfully using 50% zinc chloride and radiation
therapy. This verifies the hypothesis that 50% zinc chloride
is effective in decreasing the recurrence of GCTs. In two
of the patients who had a defective cortical bone, the
odontoid process was preserved with an axial vertebral
body resection and the axial vertebra was reconstructed
with an ilium autograft. For the fusion of the odontoid
Chen et al. World Journal of Surgical Oncology  (2015) 13:62 Page 6 of 7process, autograft ilium and third cervical vertebra, it was
necessary to implant a cervical spinal plate through the
anterior approach. Consistent with a previous study [19],
either β-TCP artificial bone or autograft ilium bone, de-
pending on the defection volume of the pathological bone,
were the potential biological implants.
To stabilize the reconstruction after axial vertebral body
resection, it has been reported that atlanto-occipital joint
fixation and posterior fusion is the most frequently used
surgical technique in the literature. Without a doubt, the
function of the atlanto-occipital joint is almost lost after
fixation and fusion. However, it is not necessary to fix the
atlanto-occipital joint, especially in cases where the atlas
vertebra and odontoid process are intact. In our study, the
pedicle of the atlas vertebral arch (C1) and lateral mass of
the third/fourth vertebra (C3 and C4) were fixed together
instead. This not only immobilized the C1-C3 efficiently,
but also greatly preserved the structure of odontoid process
and function of atlanto-occipital joint. Also, we completed
the treatment of GCTs of the axial vertebra by the posterior
and anterior approaches in one stage, which was a time- and
cost-effective way for the patients.
Due to the complex anatomy of the axial vertebra and
the variable aggressiveness of GCTs, it was substantially
difficult to resect the tumor mass and to eliminate
scattered tumor cells. Thus, a suitable adjuvant therapy
seemed necessary to control the tumor cell scatter. In
studies by Chakravarti et al. [38] and Shi W et al. [39], it
was demonstrated that adjuvant radiation therapy could
control the recurrence of GCTs, however, it also induced
serious radiation myelopathy. Nevertheless, the use of
three-dimensional conformal radiation therapy altered the
adverse reaction of radiation therapy. Further, accurate
localization and adjustable dose prevented the spinal cord
from radiation injury. In our study, no recurrence or com-
plication was observed during the follow-up periods.
Conclusions
There are only a few case reports in the literature and
no large numbers of clinical trials about treatment of,
and research into, axial vertebra (C2) GCTs. In this study,
the odontoid process and function of upper cervical verte-
bra was preserved successfully through lesional curettage,
combined with reconstruction with bone grafting, and
adjuvant radiation therapy after surgery. During the
follow-up periods, no recurrence or complications re-
lated were observed. Due to the small sample size of
this study, the results should be examined cautiously. Lar-
ger, high-quality clinical trials are required to strengthen
and verify these conclusions.
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